Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Raul F. Argilagos"'
Autor:
Lori A. Hazlehurst, Mark L. McLaughlin, John M. Koomen, Raul F. Argilagos, Michael F. Emmons, Rajesh R. Nair, Priyesh Jain, Anthony W. Gebhard
PDF file - 100K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4cf1db07a2a26702593051934a8752
https://doi.org/10.1158/1535-7163.22497660.v1
https://doi.org/10.1158/1535-7163.22497660.v1
Autor:
Lori A. Hazlehurst, Mark L. McLaughlin, John M. Koomen, Raul F. Argilagos, Michael F. Emmons, Rajesh R. Nair, Priyesh Jain, Anthony W. Gebhard
PDF file - 903K, Supplementary Figure S1: MTI-101 is more potent in U266 cell line than linear parent peptide and biotinylated peptides still retain bioactivity; Supplementary Figure S2: Biotin-HYD1 binding complex in NCI-H929 and U266 MM cell lines;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70be2e850c73a85497dce9e466ca637d
https://doi.org/10.1158/1535-7163.22497657.v1
https://doi.org/10.1158/1535-7163.22497657.v1
Autor:
Lori A. Hazlehurst, Mark L. McLaughlin, John M. Koomen, Raul F. Argilagos, Michael F. Emmons, Rajesh R. Nair, Priyesh Jain, Anthony W. Gebhard
Our laboratory recently reported that treatment with the d-amino acid containing peptide HYD1 induces necrotic cell death in multiple myeloma cell lines. Because of the intriguing biological activity and promising in vivo activity of HYD1, we pursued
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ed3cd763c19815b7f2427753ebe2253
https://doi.org/10.1158/1535-7163.c.6535680
https://doi.org/10.1158/1535-7163.c.6535680
Autor:
Lori A. Hazlehurst, William S. Dalton, Hong-Gong Wang, William T. Kerr, Kit Lam, Raul F. Argilagos, Anne E. Cress, Michael F. Emmons, Rajesh R. Nair
Supplementary Data from HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cb1d9e5b7c1bd999451dce00fd66eef
https://doi.org/10.1158/1535-7163.22484849.v1
https://doi.org/10.1158/1535-7163.22484849.v1
Autor:
Lori A. Hazlehurst, William S. Dalton, Hong-Gong Wang, William T. Kerr, Kit Lam, Raul F. Argilagos, Anne E. Cress, Michael F. Emmons, Rajesh R. Nair
HYD1 is a D–amino acid peptide that was previously shown to inhibit adhesion of prostate cancer cells to the extracellular matrix. In this study, we show that in addition to inhibiting adhesion of multiple myeloma (MM) cells to fibronectin, HYD1 in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5457eb29e9457d4ff0481b86248540bc
https://doi.org/10.1158/1535-7163.c.6531617.v1
https://doi.org/10.1158/1535-7163.c.6531617.v1
Autor:
Lori A. Hazlehurst, Raul F. Argilagos, Rajesh R. Nair, Ling Zhang, Javier Pinilla-Ibarz, Joel H. Tolentino
Publikováno v:
Leukemia Research. 36:756-763
In this study, we show that conditioned media (CM) generated from bone marrow (BM)-derived mesenchymal stromal cells lead to BCR-ABL independent STAT3 activation. Activation of STAT3 is important not only for survival of CML cells but also for its pr
Autor:
William S. Dalton, Anne E. Cress, Michael F. Emmons, Rajesh R. Nair, Kit S. Lam, Raul F. Argilagos, Lori A. Hazlehurst, Hong Gong Wang, William T. Kerr
Publikováno v:
Molecular Cancer Therapeutics. 8:2441-2451
HYD1 is a D–amino acid peptide that was previously shown to inhibit adhesion of prostate cancer cells to the extracellular matrix. In this study, we show that in addition to inhibiting adhesion of multiple myeloma (MM) cells to fibronectin, HYD1 in
Publikováno v:
British Journal of Haematology. 136:269-275
It has been shown that the tumour microenvironment confers resistance to chemotherapy. Specifically, it was previously reported that adhesion of haematopoietic tumour cells to fibronectin (FN) via beta1 integrins confers a multi-drug resistance pheno
Autor:
Mark L. McLaughlin, Raul F. Argilagos, Anthony W. Gebhard, Rajesh R. Nair, Lori A. Hazlehurst, John M. Koomen, Priyesh Jain, Michael F. Emmons
Publikováno v:
Molecular cancer therapeutics. 12(11)
Our laboratory recently reported that treatment with the d-amino acid containing peptide HYD1 induces necrotic cell death in multiple myeloma cell lines. Because of the intriguing biological activity and promising in vivo activity of HYD1, we pursued
Publikováno v:
2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
Biophotonic imaging can be used to characterize tumor growth in animal models. Estimation of the numbers and location of target cells is dependent on accurate segmentation of a target region from the background luminescence of the animal body. Existi